News Sentiment

BSLN sentiment intelligence

Basilea Pharmaceutica AG news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 50 Balanced news tone 2 relevant articles
Exchange EBS Switzerland
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 54.70 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

58/100 classification confidence.

Company focus 2

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+0.7% over one week, +9.7% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Basilea joins INCATE to support antifungal innovation

Market Reaction

Balanced read

40/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 58/100 classification
One-week reaction 0.7% Price digesting
Trend fit Trend inactive 9.7% over four weeks
Fair value 21.4% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 2
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 2
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
GlobeNewswire 1
marketscreener.com 1

Event Lens

What the news is about

Classified themes
Market update 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-2 of 2